KRAS and neoplasm: The CAM assay was performed to evaluate tumor growth of H292 KRAS mutant cell lines, and we found a significant increase in tumor perimeter of both KRAS mutant cells, compared to wild-type (Figure 3F and Supplementary Figure S2A).